Home  >  Pharma People
Eppen_CellXpert_Nov24
you can get e-magazine links on WhatsApp. Click here
Pharma People
+ Font Resize -

Lupin appoints Claus Jepsen as president, global specialty

Our Bureau, Mumbai
Tuesday, October 22, 2024, 14:15 Hrs  [IST]

Global pharma major Lupin Limited (Lupin) announced the appointment of Claus Jepsen as president, global specialty. He brings over three decades of experience in commercial strategy, portfolio management, and launch planning across Europe, Asia, and the United States. Claus joins Lupin from Takeda Pharmaceuticals, where he led the global strategy for rare diseases. Prior to that Claus was at GlaxoSmithKline, where he served in many roles including country head in Asia, and global franchise management in immunology, respiratory and neurology therapeutic areas. Claus has launched major brands like Ellipta in the US and led Advair and Seretide success in Europe and US.
 
Commenting on the appointment, Lupin’s CEO, Vinita Gupta said, “We are delighted to welcome Claus to our executive leadership team. His experience in leading specialty strategy, commercial planning and portfolio choices across key markets will enable us to build our Specialty brand business.”
 
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.

 
Follow on LinkedIn
Post Your commentsPOST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
avians24_PB
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram